Additionally, the phytopharmaceutical acted more effectively against proliferation and for p53-related anti-plasticity/pro-apoptosis induction in these CRC cells as in HepG2 liver cancer cells at a concentration range between 25 μM and 100 μM [146] emphasizing resveratrol‘s special suitability as CRC inhibitor (Table 3). Here, TP53 is linked to colorectal carcinoma.